BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30303324)

  • 1. [Spontaneous involution of Vestibular Schwannomas].
    Bussard J; Tuleasca C; Maire R
    Rev Med Suisse; 2018 Oct; 14(621):1739-1741. PubMed ID: 30303324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal outcomes for hearing preservation in the management of small vestibular schwannomas.
    Peng KA; Wilkinson EP
    J Laryngol Otol; 2016 Jul; 130(7):606-10. PubMed ID: 27198728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consequences to hearing during the conservative management of vestibular schwannomas.
    Walsh RM; Bath AP; Bance ML; Keller A; Rutka JA
    Laryngoscope; 2000 Feb; 110(2 Pt 1):250-5. PubMed ID: 10680925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of hearing deterioration in intracanalicular vestibular schwannoma.
    Pennings RJ; Morris DP; Clarke L; Allen S; Walling S; Bance ML
    Neurosurgery; 2011 Jan; 68(1):68-77. PubMed ID: 21099722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiologic Features of Spontaneous Regression of Vestibular Schwannomas.
    Vellutini EAS; Teles Gomes MQ; Brock RS; Oliveira MF; Salomone R; Godoy LFS; Ruschel LG
    World Neurosurg; 2020 Mar; 135():e488-e493. PubMed ID: 31843724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Factors of Hearing Outcome in Untreated Vestibular Schwannomas: Implication of Subdivision of Their Growth by Volumetric Analysis.
    Joo JD; Oh SJ; Kim YH; Han JH; Choi BY; Koo JW; Kim CY
    World Neurosurg; 2017 Oct; 106():768-774. PubMed ID: 28751138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gamma Knife radiosurgery for vestibular schwannoma: clinical results at long-term follow-up in a series of 379 patients.
    Boari N; Bailo M; Gagliardi F; Franzin A; Gemma M; del Vecchio A; Bolognesi A; Picozzi P; Mortini P
    J Neurosurg; 2014 Dec; 121 Suppl():123-42. PubMed ID: 25434946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term hearing preservation in vestibular schwannoma.
    Stangerup SE; Thomsen J; Tos M; Cayé-Thomasen P
    Otol Neurotol; 2010 Feb; 31(2):271-5. PubMed ID: 19887973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conservative management of vestibular schwannoma: Predictors of growth and hearing.
    Jethanamest D; Rivera AM; Ji H; Chokkalingam V; Telischi FF; Angeli SI
    Laryngoscope; 2015 Sep; 125(9):2163-8. PubMed ID: 25647714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis and Management of Vestibular Schwannomas - An Interdisciplinary Challenge].
    Rosahl S; Bohr C; Lell M; Hamm K; Iro H
    Laryngorhinootologie; 2017 Apr; 96(S 01):S152-S182. PubMed ID: 29036751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric neurofibromatosis type 2: clinical and molecular presentation, management of vestibular schwannomas, and hearing rehabilitation.
    Bonne N-; Aboukais R; Baroncini M; Hochart A; Leblond P; Broly F; Dubrulle F; Lejeune JP; Vincent C
    Childs Nerv Syst; 2016 Dec; 32(12):2403-2413. PubMed ID: 27704245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vestibular Schwannoma: The Evolution of Hearing and Tumor Size in Natural Course and after Treatment by LINAC Stereotactic Radiosurgery.
    Ikonomidis C; Pica A; Bloch J; Maire R
    Audiol Neurootol; 2015; 20(6):406-15. PubMed ID: 26571111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Otorhinolaryngologic findings in acoustic neuroma with special reference to vestibular symptoms].
    Futschik D; Mikulin D
    Z Arztl Fortbild (Jena); 1982 Mar; 76(5):184-5. PubMed ID: 7080541
    [No Abstract]   [Full Text] [Related]  

  • 14. Predictors of hearing outcomes following low-dose stereotactic radiosurgery in patients with vestibular schwannomas: A retrospective cohort review.
    Lin RH; Wang TC; Lin CD; Lin HL; Chung HK; Wang CY; Tsou YA; Tsai MH
    Clin Neurol Neurosurg; 2017 Nov; 162():16-21. PubMed ID: 28892717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic radiosurgery for neurofibromatosis 2-associated vestibular schwannomas: toward dose optimization for tumor control and functional outcomes.
    Mallory GW; Pollock BE; Foote RL; Carlson ML; Driscoll CL; Link MJ
    Neurosurgery; 2014 Mar; 74(3):292-300; discussion 300-1. PubMed ID: 24335819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost analysis of vestibular schwannoma screening with contrast-enhanced magnetic resonance imaging in patients with asymmetrical hearing loss.
    Pan P; Huang J; Morioka C; Hathout G; El-Saden SM
    J Laryngol Otol; 2016 Jan; 130(1):21-4. PubMed ID: 26365591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and Diagnostic Characteristics of Vestibular Schwannomas-Does Gender Matter?
    Reznitsky M; Petersen MMBS; West N; Stangerup SE; Cayé-Thomasen P
    Otol Neurotol; 2020 Dec; 41(10):e1372-e1378. PubMed ID: 33492815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Unusual clinical presentations of vestibular schwannomas].
    Coca Pelaz A; Rodrigo JP; Llorente JL; Gómez JR; Suárez C
    Acta Otorrinolaringol Esp; 2008 Apr; 59(4):187-9. PubMed ID: 18447978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A purely intracanalicular cochlear schwannoma presenting with progressive hearing loss.
    Işıldak H; Ibrahimov M; Yilmaz M; Enver O; Albayram S
    Ear Nose Throat J; 2011 Oct; 90(10):481-8. PubMed ID: 22033959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conservative treatment of vestibular schwannoma: a follow-up study on clinical and quality-of-life outcome.
    Godefroy WP; Kaptein AA; Vogel JJ; van der Mey AG
    Otol Neurotol; 2009 Oct; 30(7):968-74. PubMed ID: 19730147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.